SCHEMBL13408873

SCHEMBL13408873

c1ccc(-p2c3ccccc3c3cc(-c4cc5cc(-c6ccc7ccccc7c6)c6ccccc6c5c5ccccc45)ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.38
▸ GSTP1 P09211 1/20 0.37
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ HDAC4 P56524 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ CYP1A2 P05177 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ DHFR P00374 1/20 0.31
▸ CYP11B1 P15538 3/20 0.31
▸ CYP11B2 P19099 2/20 0.31
▸ CYP17A1 P05093 1/20 0.31
▸ CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13408727 0.93 ALDH1A1 (0.31) ALDH1A1HSD17B10CYP11B1HPGDTSHR
SCHEMBL13408699 0.91 — —
SCHEMBL13408823 0.91 HPGD (0.34) GPR84ALDH1A1KDM4EMEN1KMT2A
SCHEMBL13408875 0.87 MCL1 (0.36) GPR84ALDH1A1KDM4EHSD17B10MEN1
SCHEMBL13408736 0.86 ALDH1A1 (0.31) ALDH1A1HSD17B10HPGDTSHRMAPK1
SCHEMBL13408742 0.83 GSTP1 (0.30) GSTP1
SCHEMBL13706126 0.83 HSD17B1 (0.38) GPR84GSTP1ADORA2AADORA1CYP1A2
SCHEMBL13706166 0.81 CYP11B1 (0.36) GPR84ADORA2AADORA1ALDH1A1KDM4E
SCHEMBL13706285 0.80 CYP11B1 (0.41) GPR84ALDH1A1KDM4EHSD17B10MEN1
SCHEMBL13520278 0.77 PTGS2 (0.41) GPR84GSTP1ADORA2AADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 — — US disclosed
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 — — US disclosed
EP-2161319-A2 Benzo(c)phenanthrene derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-03-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same OCIAD1, OR10J3, ORMDL3 GPR84 1571/4885GSTP1 1996/4885ADORA2A 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback